Should We All Be Getting Full Body MRIs?
Could a full body MRI hurt more than it helps?
A patient sent her doctor a report after getting one of the increasingly popular full body MRIs being advertised all over social media.
They hadn’t discussed it beforehand.
The report was long. Beautifully designed. Color-coded. Written in clear, reassuring language. It looked comprehensive in a way most routine medical reports do not.
And that, honestly, is part of the appeal.
Because most people don’t experience the healthcare system as clean, straightforward, and confidence-inspiring. They experience it as fragmented. They wait weeks for referrals. They juggle multiple appointments. They get portal messages full of jargon. They sit through rushed visits that leave them feeling like they’re only scratching the surface.
So when a company offers one scan that promises to look from head to toe—and catch the thing no one else would have caught—it lands.
Especially in an era where we are constantly being shown stories of the “healthy” person who suddenly turned out not to be healthy at all.
The widow on Instagram whose husband died young of something no one saw coming.
The friend-of-a-friend with surprise pancreatic cancer.
The headline about the marathon runner with a hidden aneurysm.
These stories are emotionally powerful. They stay with us. And they make a certain question feel impossible to ignore:
If there’s a way to look everywhere, why wouldn’t I do it?
So let’s slow down and ask the bigger question:
Should we all be getting full body MRIs?
The Claim
The pitch for direct-to-consumer full body MRI screening goes something like this: in a single scan covering your head, neck, chest, abdomen, pelvis, and legs, you can screen for solid tumors, brain aneurysms, spine degeneration, metabolic disorders, autoimmune conditions, and more — all without a referral, all without insurance hassle, and all with a beautifully written report delivered straight to you. Testimonials on company websites describe catching cancers that dramatically improved survival odds. The recurring themes are early detection and, perhaps most powerfully, peace of mind.
Why It’s Going Viral
The emotional truth underneath this trend is real, and it deserves to be named before we get into the science.
Health anxiety is at an all-time high — and social media is part of why. Algorithms serve us the most emotionally engaging content, which means our feeds are full of stories of people whose lives were upended by a diagnosis that came out of nowhere. The GoFundMe. The “I had no symptoms.” The before and after. These stories are harrowing precisely because they feel random, and our brains are wired to look for a way to make randomness feel controllable.
At the same time, navigating the traditional healthcare system for even basic screenings is genuinely hard. Getting a mammogram, a colonoscopy, a pap smear, a lung CT (if you qualify) often means multiple appointments with multiple providers spread across multiple weeks. It means referrals, insurance approvals, time off work, childcare. The system makes prevention feel like a second job. So when someone offers you a single appointment that promises to check everything, it’s not irrational to be interested.
There’s also a growing cultural narrative — amplified significantly online — that what your doctor offers you is barely scratching the surface. That “medicine 3.0” and biohacking and optimization represent a higher tier of care. That the reason your physician isn’t ordering these things isn’t because they’ve weighed the evidence, but because of gatekeeping, cost containment, or simply being behind the curve. For patients who have felt dismissed or under-served by the medical system — and many have, for entirely valid reasons — this narrative has a lot of traction.
All of this makes sense. The desire for a comprehensive, clear, reassuring picture of your health is deeply human. It doesn’t make someone gullible or naive to want it. And that’s exactly why we think this conversation matters.
What the Science Shows
Let’s start with what’s true: screening works. There are genuinely conditions where catching something before you have symptoms can change the outcome, sometimes dramatically. Pap smears, mammograms, colonoscopies, blood pressure checks — these are recommended precisely because the evidence shows they improve outcomes at a population level. The concept behind full body MRI screening isn’t invented from nothing.
There are also specific, evidence-based clinical situations where whole body MRI is genuinely useful — patients with certain rare genetic syndromes that carry high cancer risk, specific rare cancers where staging benefits from full-body imaging, certain inflammatory or infectious conditions. This isn’t fringe medicine. It’s just that these situations are uncommon, and none of them describe the general population being targeted by direct-to-consumer companies.
For asymptomatic, average-risk adults, a 2019 systematic review published in the looked at twelve studies involving more than 5,000 subjects and found that the pooled prevalence of “critical or indeterminate” incidental findings was 32%. Read that again: nearly a third of healthy people who got these scans had something found. That sounds reassuring — until you look at what happened next. When those findings were verified through follow-up testing, the rate dropped to about 12.6%. About sixteen percent of findings were false positives — meaning they prompted additional testing, additional cost, and potential additional risk, and ultimately turned out to be nothing.
False positives aren’t just inconvenient. They lead to more imaging (sometimes with radiation or contrast dye), biopsies, and procedures — each with their own risk profiles. They consume time, money, and enormous amounts of mental and emotional energy. And once a finding is documented, the medical system essentially requires that it be followed — even when the clinical probability that it represents anything significant is very low.
It’s also worth understanding what these scans miss. According to the companies’ own fine print: they don’t evaluate the mucosal lining of the GI tract (meaning they won’t catch early colon cancer the way a colonoscopy would), they don’t replace dedicated breast imaging, they have limitations in assessing lung micro-nodules, they don’t visualize smaller brain vessels, and they cannot detect common conditions like high blood pressure, diabetes, prediabetes, or thyroid disease. In a single scan lasting 45 to 60 minutes covering the entire body, the resolution is simply not what you’d get from a targeted, high-quality study of a specific organ.
Clinical Nuance
None of this means that if you’ve had one of these scans, you made a terrible mistake. It means the conversation is more complicated than the marketing suggests.
Thoughtful clinicians think about tests the way they think about any intervention: what is this likely to find? What will we do if it finds something? Will knowing that thing change the outcome — or will it primarily generate anxiety, follow-up appointments, and cascade testing without meaningfully improving your health? These aren’t bureaucratic questions. They’re the actual questions that determine whether a test helps you or harms you.
There’s also the question of what these scans replace versus what they add. For someone who can’t access the traditional healthcare system, there’s a real risk that a full body MRI becomes a substitute for evidence-based screenings rather than a supplement to them. A beautiful report doesn’t replace a colonoscopy. It doesn’t replace a mammogram. And the illusion that it might is one of the more quietly concerning aspects of how these products are marketed.
That said: people have different values, different risk tolerances, different relationships to uncertainty. If you have the resources, you’ve already completed all recommended evidence-based screenings, you understand the limitations, and you’re making this decision in consultation with a physician who knows your full history — that’s a different conversation than someone using this as their primary health screening in place of established care.
What we’d ask for, from the companies offering these services, is honest and prominent informed consent — not in the fine print, but front and center. What this scan can and cannot detect. What it means if something is found. What follow-up typically looks like. The rate of incidental findings and false positives. That’s the kind of transparency that would let people make genuinely informed choices.
The Antidote
For Patients
(Gentle reminders and affirmations)
It makes sense that I want to avoid a surprise diagnosis.
Wanting more information about my health is not irrational.
A full body MRI is not the same thing as a full body guarantee.
A normal scan does not rule out every serious condition.
An abnormal scan does not always mean something dangerous was found.
Before I pay for an optional screening test, I deserve to understand what it can detect, what it cannot detect, and what happens if it finds something incidental.
For Clinicians
(Language you can borrow, tweak, or make your own)
“I understand why this feels appealing—especially when healthcare already feels so fragmented.”
“This scan is not a replacement for your usual screening tests.”
“The question isn’t only whether it can find something. It’s whether finding that thing actually improves your outcome.”
“One of the main risks of broad imaging is incidental findings that lead to more testing, more cost, and sometimes procedures for things that may never have harmed you.”
“If this is something you’re still considering, let’s make sure you understand the limitations and are prepared for what follow-up might look like.”
“Our goal is not just more information. It’s information that actually helps you.”
Sources and Further Reading
Clinical Applications and Controversies of Whole-Body MRI: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2023.
Whole-body MRI for preventive health screening: A systematic review of the literature. J Magn Reson Imaging. 2019.
Whole-body MRI for preventive health screening: Management strategies and clinical implications. Eur J Radiol. 2021.
A Practical Guide to MR Imaging Safety: What Radiologists Need to Know. Radiographics. 2015.